OOIR: Observatory of International Research

Papers

(The H4-Index of Drug and Alcohol Dependence is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Letter to the Editor regarding: Is implementation of ASAM-based addiction treatment assessments associated with improved 30-day retention and substance use? (By Mark et al., 2021)	291
A novel long-acting formulation of oral buprenorphine/naloxone produces prolonged decreases in fentanyl self-administration by rhesus monkeys	212
Development and validation of the Schedule for the Assessment of Insight in Alcohol Dependence (SAI-AD): Dimensions and correlates of insight in alcohol use disorder	126
Genetic Insights into the causal relationship between cannabis use and diabetic phenotypes: A genetic correlation and Mendelian randomization study	119
Editorial Board	96
Editorial Board	89
Access to methadone clinics and opioid overdose deaths in Georgia: A geospatial analysis	87
Reduced neural functional connectivity during working memory performance in methamphetamine use disorder	83
EFFECTS OF SOCIAL DEFEAT STRESS EXPOSURE ON SPATIAL MEMORY PERFORMANCE IN SOCIALLY MONOGAMOUS MALE PRAIRIE VOLES	78
EXPLORING ASSOCIATIONS BETWEEN TRADITIONAL GENDER NORMS AND PRE-IMMIGRATION SEXUAL RISK BEHAVIORS AMONG MALE & FEMALE RECENT LATINO/A IMMIGRANTS	73
SEX AND GENOTYPE DEPENDENT DRUG-INDUCED DOPAMINE RELEASE IN ADOLESCENT CHRNA6 3’-UTR RATS	67
Does substance use disorder treatment completion reduce the risk of treatment readmission in Chile?	64
Pilot randomized trial of cognitive-behavioral treatment plus contingency management for quitting smoking and weight gain prevention among smokers with overweight or obesity	60
Neighborhood disadvantage and prescription drug misuse in low-income urban mothers	60
Corrigendum to “Predictors of enrollment in opioid agonist therapy after opioid overdose or diagnosis with opioid use disorder: A cohort study” [Drug and Alcohol Dependence 219 (2021) 108435]	59
A randomized pilot trial of two forms of behavioral economics intervention to improve engagement in buprenorphine-naloxone treatment among patients with opioid use disorder	55
The use of Australian SMART Recovery groups by people who use methamphetamine: Analysis of routinely-collected nationwide data	54
Correlates of solitary alcohol and cannabis use among American Indian adolescents	54
Effects of access condition on substance use disorder-like phenotypes in male and female rats self-administering MDPV or cocaine	50
Social addiction or nicotine addiction? The effect of smoking social motivation on inhibitory control under smoking social cues: Evidence from ERPs	49
Ethnic density effect on alcohol-related hospitalizations among Chinese enclaves and ethnoburbs in California, 2007–2011	49
Corrigendum to “Longitudinal latent class analysis of tobacco use and correlates among young adults over a 10-year period” [Drug Alcohol Depend. 236 (2022) 109474]	49
The moderating role of resilience in the relationship between experiences of COVID-19 response-related discrimination and disinformation among people who inject drugs	48
Generational shifts in attitudes and beliefs about alcohol: An age-period-cohort approach	48
Impact of the Russian invasion on opioid agonist therapy programs in Ukraine: A qualitative study	47

Why do Americans use marijuana?	46
Socioeconomic inequalities in alcohol consumption in Argentina: Comparative analysis from 2009, 2013, and 2018	45
Validation of a single question for the assessment of past three-month alcohol consumption among adolescents	45
Disclosure processes as predictors of relationship outcomes among people in recovery from opioid use disorder: A longitudinal analysis	43
The effects of combination levodopa-ropinirole on cognitive improvement and treatment outcome in individuals with cocaine use disorder: A bayesian mediation analysis	42
Prescription opioid use and employment: A nationwide Finnish register study	42
Use of laboratory data for illicit drug use surveillance and identification of socioeconomic risk factors	41
Comparing Racial and Ethnic Differences on Access to Wellness Services for People in Substance Use Treatment	40
Receiving Medications for Opioid Use Disorder in Maryland Correctional Facilities and at a Community-Based Low-Threshold Buprenorphine Program Post-Release: Patient and Staff Perspectives	40
Misuse Potential of Medicinal Ketamine in Real-World Clinical Contexts, Part 1: Patients With At-Home Prescribed Ketamine	39
Sex Differences in Contextual Cocaine Seeking Behavior are Driven by Noradrenergic Signaling to the Dorsal Hippocampus	39
Risky Polysubstance Use Among People who Use Opioids in a Community-Based Study	39
UTILIZING INNOVATIVE APPROACHES TO ENHANCE THE FULL POTENTIAL OF SUBSTANCE USE DATA TO BENEFIT MINORITIZED POPULATIONS	39
Guanfacine Reduces Drug Craving, Stress and Increases the Number of Abstinence Days in Women With Polysubstance Use Disorder (PSUD): A Pilot 2-Site Clinical Study	38